Karen Marder

47.6k total citations · 3 hit papers
341 papers, 24.8k citations indexed

About

Karen Marder is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Karen Marder has authored 341 papers receiving a total of 24.8k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Neurology, 87 papers in Cellular and Molecular Neuroscience and 83 papers in Psychiatry and Mental health. Recurrent topics in Karen Marder's work include Parkinson's Disease Mechanisms and Treatments (141 papers), Dementia and Cognitive Impairment Research (66 papers) and Genetic Neurodegenerative Diseases (59 papers). Karen Marder is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (141 papers), Dementia and Cognitive Impairment Research (66 papers) and Genetic Neurodegenerative Diseases (59 papers). Karen Marder collaborates with scholars based in United States, Israel and Canada. Karen Marder's co-authors include Yaakov Stern, Richard Mayeux, Diane M. Jacobs, Karen L. Bell, Ming‐Xin Tang, Lucien Côté, L. Côté, G. Dooneief, Howard Andrews and Jason Brandt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Karen Marder

340 papers receiving 24.1k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

2012 1.9k citations Karen Marder et al. Movement Disorders profile →
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

1996 1.3k citations Yaakov Stern, Karen Marder et al. profile →
Mild cognitive impairment in Parkinson disease

2010 569 citations Karen Marder et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Marder United States	85	12.1k	6.4k	6.1k	5.0k	3.3k	341	24.8k
Lawrence A. Hansen United States	70	4.0k 0.3×	4.0k 0.6×	10.4k 1.7×	5.2k 1.0×	2.2k 0.7×	170	18.6k
Nelson Butters United States	80	3.7k 0.3×	8.5k 1.3×	5.9k 1.0×	5.4k 1.1×	12.4k 3.8×	239	25.4k
David P. Salmon United States	94	3.8k 0.3×	16.1k 2.5×	10.8k 1.8×	4.2k 0.8×	12.0k 3.7×	400	33.1k
Peter Paul De Deyn Belgium	80	3.3k 0.3×	4.9k 0.8×	6.5k 1.1×	3.6k 0.7×	4.3k 1.3×	623	24.7k
Joel H. Kramer United States	90	5.3k 0.4×	11.8k 1.9×	7.8k 1.3×	1.7k 0.3×	10.4k 3.2×	473	28.9k
Steven E. Arnold United States	89	3.5k 0.3×	7.8k 1.2×	10.1k 1.7×	4.6k 0.9×	4.6k 1.4×	344	28.1k
Allen D. Roses United States	77	3.8k 0.3×	6.0k 0.9×	17.9k 3.0×	5.7k 1.1×	1.6k 0.5×	357	34.7k
Juan C. Troncoso United States	87	7.3k 0.6×	2.2k 0.3×	9.5k 1.6×	6.6k 1.3×	1.3k 0.4×	318	26.0k
Paul Maruff Australia	81	1.8k 0.1×	10.3k 1.6×	6.3k 1.0×	1.7k 0.3×	7.9k 2.4×	573	26.4k
Anne M. Fagan United States	86	2.2k 0.2×	9.5k 1.5×	15.2k 2.5×	3.9k 0.8×	5.2k 1.6×	290	26.3k

Countries citing papers authored by Karen Marder

Since Specialization

Citations

This map shows the geographic impact of Karen Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Marder more than expected).

Fields of papers citing papers by Karen Marder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Marder. The network helps show where Karen Marder may publish in the future.

Co-authorship network of co-authors of Karen Marder

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Marder. A scholar is included among the top collaborators of Karen Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Marder. Karen Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talmasov, Daniel, Patrick J. Brown, Frank A. Provenzano, et al.. (2025). Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive Adults. American Journal of Geriatric Psychiatry. 33(7). 756–769. 1 indexed citations

Kost, Rhonda G., Joseph Andrews, Ranee Chatterjee, et al.. (2025). What research participants say about their research experiences in Empowering the Participant Voice: Outcomes and actionable data. Journal of Clinical and Translational Science. 9(1). e43–e43. 3 indexed citations

Michaelis, T., Cecilia S. Lindestam Arlehamn, April Frazier, et al.. (2025). Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. Nature. 647(8091). 970–978. 1 indexed citations

Chapman, Silvia, Richard Mayeux, Mary E. D’Alton, et al.. (2024). Confronting Alzheimer’s Disease Risk in Women: A Feasibility Study of Memory Screening as Part of the Annual Gynecological Well-Woman Visit. Journal of Women s Health. 33(9). 1211–1218.

Idnay, Betina, Gongbo Zhang, Casey Ta, et al.. (2024). Mini-mental status examination phenotyping for Alzheimer’s disease patients using both structured and narrative electronic health record features. Journal of the American Medical Informatics Association. 32(1). 119–128. 1 indexed citations

Honig, Lawrence S., Radhika Jagannathan, Karen Marder, et al.. (2024). Clinical Use of Lecanemab at an Academic Medical Center. Alzheimer s & Dementia. 20(S8). 2 indexed citations

Cook, Lola, Tae‐Hwi Schwantes‐An, Laurence E. Walsh, et al.. (2024). Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation. npj Parkinson s Disease. 10(1). 202–202. 2 indexed citations

Idnay, Betina, et al.. (2023). Clinical research staff perceptions on a natural language processing-driven tool for eligibility prescreening: An iterative usability assessment. International Journal of Medical Informatics. 171. 104985–104985. 2 indexed citations

Marder, Karen, et al.. (2023). Clinical research resource support for off‐site research coordinators in intensive and specialty care units. Clinical and Translational Science. 16(6). 915–921. 1 indexed citations

10.

Agin‐Liebes, Julian, Richard A. Hickman, Jean Paul Vonsattel, et al.. (2023). Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders. 38(8). 1541–1545. 5 indexed citations

11.

Goldman, Jill, Wendy R. Uhlmann, Ali Naini, Robert Klitzman, & Karen Marder. (2023). Genetic Testing of HTT Modifiers for Huntington's Disease: Considerations for Clinical Guidelines. Movement Disorders. 38(12). 2151–2154. 3 indexed citations

12.

Surface, Matthew, Manisha Balwani, Cheryl Waters, et al.. (2021). Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease. Movement Disorders. 37(2). 416–421. 28 indexed citations

13.

Tam, Eric, et al.. (2018). Interest in Genetic Testing in Parkinson’s disease patients with Deep Brain Stimulation (P4.069). Neurology. 90(15_supplement). 2 indexed citations

14.

Saunders‐Pullman, Rachel, Anat Mirelman, Roy N. Alcalay, et al.. (2018). Progression in the LRRK2-Associated Parkinson Disease Population. JAMA Neurology. 75(3). 312–312. 94 indexed citations

15.

Pal, Gian, Deborah A. Hall, Bichun Ouyang, et al.. (2016). Genetic and Clinical Predictors of Deep Brain Stimulation in Young‐Onset Parkinson's Disease. Movement Disorders Clinical Practice. 3(5). 465–471. 24 indexed citations

16.

Boyd, Clara, Michael Tierney, Eric M. Wassermann, et al.. (2014). Visual Perception Test Predicts a Pathological Diagnosis of Alzheimer’s Disease in Patients Presenting with Corticobasal Syndrome (P3.202). Neurology. 82(10_supplement). 1 indexed citations

17.

Saxman, John H., et al.. (2011). Acoustic Analysis of Voice and Speech Characteristics in Presymptomatic Gene Carriers of Huntington's Disease: Biomarkers for Preclinical Sign Onset?. NSUWorks (Nova Southeastern University). 19(2). 49. 9 indexed citations

18.

Rao, Ashwini K., Lori Quinn, & Karen Marder. (2005). Reliability of spatiotemporal gait outcome measures in Huntington's disease. Movement Disorders. 20(8). 1033–1037. 64 indexed citations

19.

Cysique, Lucette A., Bruce J. Brew, Mark Halman, et al.. (2005). Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(4). 426–429. 44 indexed citations

20.

Mayeux, R., Yaakov Stern, Robert Rosenstein, et al.. (1988). An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease. Archives of Neurology. 45(3). 260–262. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact